Is this you? Create Your Porfile
Avatar

Takanari Tominaga

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Takanari Tominaga is active.

Explore More

Publication

Featured researches published by Takanari Tominaga.

Archive | 1998

Drugs, foods or drinks with the use of algae-derived physiologically active substances

Tatsuji Enoki; Hiroaki Sagawa; Takanari Tominaga; Eiji Nishiyama; Nobuto Koyama; Takeshi Sakai; Fu-Gong Yu; Katsushige Ikai; Ikunoshin Kato

Biological & Pharmaceutical Bulletin | 2012

Anti-tumor-Promoting Activities of Agaro-Oligosaccharides on Two-Stage Mouse Skin Carcinogenesis

Tatsuji Enoki; Takanari Tominaga; Fuyuko Takashima; Hiromu Ohnogi; Hiroaki Sagawa; Ikunoshin Kato

Archive | 1999

Remedies or preventives containing cyclopentenone compounds as the active ingredient

Eiji Kobayashi; Hiromu A Takarashuzoshataku Ohnogi; Hiroaki Hamoparesu-kusatsu Sagawa; Takanari Tominaga; Eiji Nishiyama; Nobuto Koyama; Katsushige Ikai; Ikunoshin Kato

Archive | 2000

4-Substituted-3,6-anhydro-galactose derivatives and their pharmaceutical use

Eiji Kobayashi; Tuo-Ping Li; Tatsuji Enoki; Takanari Tominaga; Hiroaki c; Ikunoshin Kato

Archive | 1998

4-organothio-2-cyclopentenones and 3-organothio-2-cyclopentanones, production and pharmaceutical uses thereof

Nobuto Koyama; Tatsuji Enoki; Katsushige Cnt. Res Lab Takara Shuzo co ltd Ikai; Hua-Kang Cnt. Res. Lab. Takara Shuzo co. ltd. Wu; Hiromu Ohnogi; Takanari Tominaga; Eiji Nishiyama; Michio Hagiya; Hiroaki Sagawa; Hideto Chono; Ikunoshin Kato

Archive | 2005

Use of algae-derived physiologically active substances for treating a carcinomatous disease

Tatsui Enoki; Hiroaki Sagawa; Takanari Tominaga; Eiji Nishiyama; Nobuto Koyama; Takeshi Sakai; Fu-Gong Yu; Katsushige Ikai; Ikunoshin Kato

Archive | 2000

4-Substituierte-3,6-Anhydro-Galaktosederivate und ihre pharmazeutische Verwendung 4-substituted-3,6-Anhydro-Galaktosederivate and their pharmaceutical use

Eiji Kobayashi; Tuo-Ping Li; Tatsuji Enoki; Takanari Tominaga; Hiroaki Sagawa; Ikunoshin Kato

Archive | 1999

Moyens de traitement ou de prevention contenant des composes de cyclopentenone comme principe actif

Eiji Kobayashi; Hiromu Ohnogi; Hiroaki Sagawa; Takanari Tominaga; Eiji Nishiyama; Nobuto Koyama; Katsushige Ikai; Ikunoshin Kato

Archive | 1998

Arzneimittel, speisen oder getränke mit physiologisch aktiven stoffen aus algen Medicinal food, beverages or algae with physiologically active substances from

Tatsuji Enoki; Hiroaki Sagawa; Takanari Tominaga; Eiji Nishiyama; Nobuto Koyama; Takeshi Sakai; Fu-Gong Yu; Katsushige Ikai; Ikunoshin Kato

Archive | 1998

Pharmaceutical compounds having a physiological activity such as anticancer action

Nobuto Koyama; Tatsuji Enoki; Katsushige Ikai; Hua-Kang Wu; Hiromu Ohnogi; Takanari Tominaga; Eiji Nishiyama; Michio Hagiya; Hiroaki Sagawa; Hideto Chono; Ikunoshin Kato

Explore More

Collaboration

Dive into the Takanari Tominaga's collaboration.

Top Co-Authors
Avatar

Nobuto Koyama

Osaka University

View shared research outputs
Top Co-Authors
Avatar

Tatsuji Enoki

Center for Cell and Gene Therapy

View shared research outputs
Top Co-Authors
Avatar

Hiromu Ohnogi

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors
Avatar

Eiji Kobayashi

Jichi Medical University

View shared research outputs
Top Co-Authors
Avatar

Hideto Chono

Center for Cell and Gene Therapy

View shared research outputs
Top Co-Authors
Avatar

Ikunoshin Kato

Kōchi University

View shared research outputs
Top Co-Authors
Avatar

Kaoru Kojima

Hirosaki University

View shared research outputs
Top Co-Authors
Avatar

Nobuto Koyama

Osaka University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge